Novartis: Ovarian cancer drug disappoints in trial
Thursday, May 27, 2010 - 13:21
in Health & Medicine
GENEVA (AP) -- Swiss drug maker Novartis AG said Thursday it won't ask regulators for permission to market a new ovarian cancer drug after a late-stage trial proved disappointing....